The Foundation For Autoimmune Cancer Support

Changing the Script for Patients that Receive Immunotherapy

Live Better Beyond Cancer.

What is FACS?

Here is a list of medications we are talking about called immune checkpoint inhibitors or immunotherapy (but not limited to):

  • Keytruda (pembrolizumab)
  • Opdivo (nivolumab)
  • Libtayo (cemiplimab)
  • Loqtorzi (toripalimab)
  • Tevimbra (tislelizumab)
  • Zynyz ( retifanlimab)
  • Tencentriq (atezolizumab)
  • Imfinzi (durvalumab)
  • Yervoy (ipilimumab)
  • Imjudo (tremelimumab)

Immunotherapy's Growth in Cancer Treatment

  • Broad Usage: Immunotherapy is now used in over 50% of all cancers, making it one of the dominant treatment options.
  • Impact on Mortality: Immunotherapy has been responsible for reducing cancer mortality rates by more than 30% over the past decade. This reduction is the most impressive compared to any other cancer treatment in recent years.

Challenges and Side Effects:

  • Autoimmune Side Effects: Around 80% of patients undergoing immunotherapy will experience long-term autoimmune side effects. These effects can often require additional treatment with separate drugs.
  • Chronic issues: 50% of patients will develop new chronic autoimmune conditions post immunotherapy. These conditions typically need medical intervention from a range of specialists (e.g., dermatologists, rheumatologists, gastroenterologists, etc.).

Key Points to Highlight:

  • Immunotherapy’s success in cancer treatment is undeniable, but the long-term autoimmune consequences are a major challenge for both patients and healthcare providers.
  • The need for multi-speciality medical intervention highlights the complexity of managing patients post-immunotherapy.
  • There may be a need for new approaches to manage these side effects or preventative treatments to reduce the long-term autoimmune impact

Have you experienced any of these symptoms during or after treatment?

  • Skin reactions ( recurrent rashes, itchiness, sores, thinning of the skin)
  • Nerve issues (burning, cramping, numbness, tingling)
  • Abdominal pain or cramping
  • Diarrhea
  • Ongoing Nausea
  • Fatigue or exhaustion
  • New thyroid issues
  • New onset diabetes
  • Joint/bone pain or swelling
  • Mobility issues (stiffness, weakness)
  • Shortness of breath
  • New heart problems
  • New allergies to foods or environment
  • Vision issues
  • Brain fog (change in thinking ability, confusion, lack of focus)
  • Dry eyes
  • Dry mouth ( burning, lack of saliva) 
  • Headaches
  • Or just something is not right
  • Or do you have a pre-existing autoimmune disease?

.

We see you.

We are here to help.

There are many options to help you not just survive but thrive.

New patients diagnosed with cancer will be eligible to receive immunotherapy
%
Patients will develop an autoimmune side effect requiring new doctors and medicatons
0 %
Patients can find the help they need during and after immunotherapy treatment
0 %

How can we help?

Tune In to Our Podcast

Checkpoint NOW is a leading podcast series for clinicians, researchers, and patients navigating the emerging world of autoimmune cancer support. Tune in for accessible, evidence-based conversations from leaders in the field.

Find an Expert

Use our directory to find clinicians across the world with experience in treating immunotherapy-related autoimmune issues. Make connections, get a second opinion, or find advice on treating patients.

Check out the latest research and current clinical trials.

Coming soon!